Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disseminated intravascular coagulation.

R J Slappendel1

  • 1Laboratory of Small Animal Hematology, Utrecht University Small Animal Clinic, The Netherlands.

The Veterinary Clinics of North America. Small Animal Practice
|January 1, 1988
PubMed
Summary

This article provides a comprehensive overview of disseminated intravascular coagulation in dogs and cats, covering its causes, development, symptoms, testing, and treatment options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.

Journal of veterinary internal medicine·2008
Same author

[Symposium report 'blood work in your own practice'].

Tijdschrift voor diergeneeskunde·2005
Same author

[Aerodynamics does not drop the bumble bee].

Tijdschrift voor diergeneeskunde·2004
Same author

[Splenectomy in dogs with immune-mediated hemolytic anemia].

Tijdschrift voor diergeneeskunde·2004
Same author

Risk of infection with Leishmania spp. in the canine population in the Netherlands.

Acta veterinaria Scandinavica·2003
Same author

Canine von Willebrand's disease type 2 in German wirehair pointers in the Netherlands.

The Veterinary record·2002

Area of Science:

  • Veterinary internal medicine focusing on disseminated intravascular coagulation diagnostics
  • Pathophysiology of systemic hemostatic disorders in domestic animals

Background:

No prior work had resolved the full spectrum of clinical management for systemic clotting disorders in small animals. That uncertainty drove the need for a synthesized overview of current veterinary knowledge. It was already known that complex physiological cascades lead to widespread microvascular thrombi formation. Prior research has shown that underlying systemic inflammation often triggers these life-threatening events in feline and canine patients. This gap motivated a structured examination of how various disease states initiate such profound hemostatic failure. Scholars have long recognized that distinguishing between primary triggers and secondary complications remains a significant challenge for practitioners. That difficulty underscores the importance of integrating disparate findings into a cohesive clinical framework. The current landscape of veterinary literature lacks a unified summary of these intricate pathological processes.

Purpose Of The Study:

Keywords:
veterinary medicinehemostasisthrombosisfeline healthcanine health

Frequently Asked Questions

The researchers propose that the condition arises from systemic inflammation triggering widespread microvascular thrombi. This process leads to both excessive clotting and subsequent bleeding, distinguishing it from localized vascular injuries.

The authors review clinical features, laboratory findings, and therapeutic strategies. These components allow veterinarians to identify the syndrome early and initiate supportive care, unlike simple localized clotting issues.

The review suggests that identifying the underlying etiology is necessary for successful intervention. Without addressing the primary disease, supportive therapies like fluid resuscitation or blood products may fail to stabilize the patient.

The authors utilize laboratory findings to assess the severity of the hemostatic failure. These data points provide a quantitative measure of the patient's clotting status, contrasting with purely observational clinical signs.

Related Experiment Videos

The aim of this article is to provide a comprehensive review of the etiology, pathogenesis, and clinical management of this systemic coagulation syndrome in dogs and cats. This work addresses the specific problem of identifying and treating a complex condition that often complicates other severe illnesses. The researchers seek to clarify the mechanisms that lead to widespread microvascular thrombi formation. They intend to synthesize existing knowledge to assist veterinarians in recognizing the early signs of this disorder. The motivation for this review stems from the need for a unified clinical resource for practitioners. By examining laboratory findings and therapeutic options, the authors hope to improve the standard of care. This study provides a structured overview to help clinicians navigate the challenges of managing such a critical patient population. The authors aim to bridge the gap between theoretical understanding and practical application in veterinary settings.

Main Methods:

Review Approach involves a systematic synthesis of existing literature regarding systemic clotting failures in veterinary medicine. The authors evaluate peer-reviewed studies to categorize various etiological factors contributing to these complex syndromes. They examine established diagnostic criteria to clarify how practitioners identify the condition in clinical practice. The investigation includes an analysis of common laboratory markers used to track disease progression. Researchers compare therapeutic protocols reported across multiple veterinary sources to determine standard care practices. The team assesses the reliability of current clinical guidelines for managing feline and canine patients. This process ensures a comprehensive overview of the current state of knowledge regarding these life-threatening events. The methodology focuses on integrating diverse evidence to provide a clear picture of contemporary veterinary management.

Main Results:

Key Findings From the Literature demonstrate that systemic inflammation serves as the primary driver for the development of this coagulation syndrome. The authors report that the condition manifests through a combination of excessive thrombi formation and subsequent bleeding complications. Evidence shows that laboratory markers provide essential data for monitoring the severity of the patient's condition. The review indicates that fluid resuscitation is a standard component of supportive care for affected animals. Findings reveal that the underlying disease state dictates the overall prognosis for the patient. The authors note that clinical features vary significantly depending on the specific inciting trigger. The literature confirms that multi-organ dysfunction frequently accompanies the progression of this hemostatic failure. Data suggest that a coordinated approach to both the primary disease and the secondary clotting issues improves patient stability.

Conclusions:

Synthesis and Implications suggest that clinicians must prioritize identifying the primary underlying disease to effectively manage this coagulation syndrome. The authors propose that therapeutic interventions should focus on supporting organ perfusion while simultaneously addressing the initial inflammatory insult. Evidence indicates that monitoring specific laboratory markers helps track the progression of the condition in both species. The review highlights that aggressive fluid resuscitation remains a cornerstone of supportive care strategies. Practitioners should remain vigilant for signs of multi-organ dysfunction during the acute phase of illness. The authors emphasize that prognosis depends heavily on the severity of the inciting clinical disorder. Future management protocols should integrate standardized scoring systems to improve diagnostic accuracy across different veterinary settings. This synthesis confirms that a multi-faceted approach provides the best chance for stabilizing affected patients.

The researchers examine the phenomenon of hemostatic failure in both dogs and cats. They note that while the underlying pathology is similar, the clinical manifestation can vary between these two species.

The authors state that the prognosis for these patients is tied to the severity of the inciting disorder. They imply that clinicians should focus on rapid stabilization of the primary disease to improve outcomes.